Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Dan Chen, Jianxuan Zou, Yunhui Zong, Huimin Meng, Gangli An & Lin Yang. (2016) Anti-human CD138 monoclonal antibodies and their bispecific formats: generation and characterization. Immunopharmacology and Immunotoxicology 38:3, pages 175-183.
Read now
Read now
Salah Aref, M.F. El Refaei, M. Sakrana & H. El-Nemre. (2004) Enhanced Neutrophil Apoptosis in Neutropenic Patients with Hepatosplenic Schistosomiasis: Evidence of Serum Fas Ligand. Hematology 9:1, pages 71-78.
Read now
Read now
Articles from other publishers (21)
Austin R. Anderson & Gabriel A. Cook. (2023) Recombinant expression, purification, and structural analysis of two ectodomains of Syndecan-1. Protein Expression and Purification 201, pages 106170.
Crossref
Crossref
İrem Şahver İşgör, Tayfur Toptaş & Kemal Türköz. (2022) Predictive Immune Markers for Disease Progression in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance. Turkish Journal of Hematology 39:4, pages 245-253.
Crossref
Crossref
Ting Zhou, Jinjun Cheng, Jeremiah Karrs, Theresa Davies-Hill, Svetlana D. Pack, Liqiang Xi, Manoj Tyagi, Jung Kim, Elaine S. Jaffe, Mark Raffeld & Stefania Pittaluga. (2022) Clinicopathologic and Molecular Characterization of Epstein-Barr Virus–positive Plasmacytoma. American Journal of Surgical Pathology 46:10, pages 1364-1379.
Crossref
Crossref
Zecheng Yang, Shuaitong Chen, Haoqiang Ying & Wantong Yao. (2022) Targeting syndecan-1: new opportunities in cancer therapy. American Journal of Physiology-Cell Physiology 323:1, pages C29-C45.
Crossref
Crossref
Antonio Junior Lepedda, Gabriele Nieddu, Nikos Karamanos & Marilena Formato. 2022. The Extracellular Matrix and the Tumor Microenvironment. The Extracellular Matrix and the Tumor Microenvironment
119
159
.
Mingpeng Wang, Lei Chen & Zhaojie Zhang. (2021) Potential applications of alginate oligosaccharides for biomedicine – A mini review. Carbohydrate Polymers 271, pages 118408.
Crossref
Crossref
Antonio Junior Lepedda, Gabriele Nieddu, Zoi Piperigkou, Konstantina Kyriakopoulou, Nikolaos Karamanos & Marilena Formato. (2021) Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease. Seminars in Thrombosis and Hemostasis 47:03, pages 295-307.
Crossref
Crossref
Daniel Czarnowski. (2021) Syndecans in cancer: A review of function, expression, prognostic value, and therapeutic significance. Cancer Treatment and Research Communications 27, pages 100312.
Crossref
Crossref
Sunil Rangarajan, Jillian R. Richter, Robert P. Richter, Shyam K. Bandari, Kaushlendra Tripathi, Israel Vlodavsky & Ralph D. Sanderson. (2020) Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression. Journal of Histochemistry & Cytochemistry 68:12, pages 823-840.
Crossref
Crossref
Tengteng Yu, Bharat Chaganty, Liang Lin, Lijie Xing, Boopathy Ramakrishnan, Kenneth Wen, Phillip A. Hsieh, Andrew Wollacott, Karthik Viswanathan, Hedy Adari, Shih-Feng Cho, Yuyin Li, Hailin Chen, Wenjuan Yang, Yan Xu, Gang An, Lugui Qiu, Nikhil Munshi, Gregory Babcock, Zachary Shriver, James R. Myette, Kenneth C. Anderson & Yu-Tzu Tai. (2020) VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo. Blood Cancer Journal 10:11.
Crossref
Crossref
Jessica Bertrand & Miriam Bollmann. (2019) Soluble syndecans: biomarkers for diseases and therapeutic options. British Journal of Pharmacology 176:1, pages 67-81.
Crossref
Crossref
Øystein Arlov, Finn L. Aachmann, Emadoldin Feyzi, Anders Sundan & Gudmund Skjåk-Bræk. (2015) The Impact of Chain Length and Flexibility in the Interaction between Sulfated Alginates and HGF and FGF-2. Biomacromolecules 16:11, pages 3417-3424.
Crossref
Crossref
Mohamed R. Akl, Poonam Nagpal, Nehad M. Ayoub, Sathyen A. Prabhu, Matthew Gliksman, Betty Tai, Ahmet Hatipoglu, Andre Goy & K. Stephen Suh. (2015) Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine. Oncotarget 6:30, pages 28693-28715.
Crossref
Crossref
Rajendra Gharbaran, Andre Goy, Takemi Tanaka, Jongwhan Park, Chris Kim, Nafis Hasan, Swathi Vemulapalli, Sreeja Sarojini, Madalina Tuluc, Kip Nalley, Pritish Bhattacharyya, Andrew Pecora & K Stephen Suh. (2013) Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients. Journal of Hematology & Oncology 6:1.
Crossref
Crossref
Benedict Yan, Soo Yong Tan, Ee Xuan Yau, Siok Bian Ng & Fredrik Petersson. (2011) EBV-Positive Plasmacytoma of the Submandibular Gland—Report of a Rare Case with Molecular Genetic Characterization. Head and Neck Pathology 5:4, pages 389-394.
Crossref
Crossref
Salah Aref, Doaa Abdullah, Manal Fouda, Nadia El Menshawy, Emaad Azmy, Ansaf Bassam, Aymen Menessy & Mohammed El Refaei. (2011) Neutrophil Apoptosis in Neutropenic Patients With Hepatitis C Infection: Role of Caspases 3, 10, and GM-CSF. Indian Journal of Hematology and Blood Transfusion 27:2, pages 81-87.
Crossref
Crossref
Mark R. Wick. 2011. Diagnostic Immunohistochemistry. Diagnostic Immunohistochemistry
340
368
.
Armelle Orosco, Olivia Fromigué, Céline Bazille, Natacha Entz-Werle, Pierre Levillain, Pierre J. Marie & Dominique Modrowski. (2007) Syndecan-2 Affects the Basal and Chemotherapy-Induced Apoptosis in Osteosarcoma. Cancer Research 67:8, pages 3708-3715.
Crossref
Crossref
Mark R. Wick. 2006. Diagnostic Immunohistochemistry. Diagnostic Immunohistochemistry
301
328
.
Richard Lovell, Janet A. Dunn, Gulnaz Begum, Nicola J. Barth, Tim Plant, Paul A. Moss, Mark T. Drayson & Guy Pratt. (2005) Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival. British Journal of Haematology 130:4, pages 542-548.
Crossref
Crossref
Dominique Modrowski, Armelle Orosco, Judicaël Thévenard, Olivia Fromigué & Pierre J. Marie. (2005) Syndecan-2 overexpression induces osteosarcoma cell apoptosis: Implication of syndecan-2 cytoplasmic domain and JNK signaling. Bone 37:2, pages 180-189.
Crossref
Crossref